Listen Live
Donate
 on air
    Schedule

    KCRW

    Read & Explore

    • News
    • Entertainment
    • Food
    • Culture
    • Events

    Listen

    • Live Radio
    • Music
    • Podcasts
    • Full Schedule

    Information

    • About
    • Careers
    • Help / FAQ
    • Newsletters
    • Contact

    Support

    • Become a Member
    • Become a VIP
    • Ways to Give
    • Shop
    • Member Perks

    Become a Member

    Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

    DonateGive Monthly

    Copyright 2026 KCRW. All rights reserved.

    Report a Bug|Privacy Policy|Terms of Service|
    Cookie Policy
    |FCC Public Files|

    Back to To the Point

    To the Point

    How Safe Are Our Prescription Drugs?

    With 80 people dead after using a contaminated blood thinner imported from China, the head of the Food and Drug Administration faced withering cross examination from a Congressional subcommittee this week. If a drug is tested by scientists, does that mean it's safe? What if the scientists took money from the company that made the drug?

    • rss
    • Share
    KCRW placeholderBy Lawrence O'Donnell • May 12, 2014 • 1 min read

    With 80 people dead after using a contaminated blood thinner imported from China, the head of the Food and Drug Administration faced withering cross examination from a Congressional subcommittee this week. If a drug is tested by scientists, does that mean it's safe? What if the scientists took money from the company that made the drug? Would more oversight slow down the process too much? Shouldn't the FDA be able to guarantee the safety of our prescriptions?

    • KCRW placeholder

      Lawrence O'Donnell

      MSNBC

    • Sonya Geis with wavy brown hair wearing a black dress with red accents and decorative earrings against a white background.

      Sonya Geis

      Senior Managing Editor

    • KCRW placeholder

      Katie Cooper

      Producer, 'One year Later'

    • KCRW placeholder

      Peter Pitts

      former Associate Commissioner, Food and Drug Administration

    • KCRW placeholder

      Eric Meslin

      Director of the Center for Bioethics, Indiana University

    • KCRW placeholder

      Phil Fontanarosa

      Executive Deputy Director, Journal of the American Medical Association

      NewsNationalPolitics
    Back to To the Point